CoChat

The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities

Brandimarti, Renato, Irollo, Elena, Meucci, Olimpia · 2023 · Molecular Neurobiology
Cited by 3

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Alteration of neuronal protein processing is often associated with neurological disorders and is highly dependent on cellular protein trafficking. A prime example is the amyloidogenic processing of amyloid precursor protein (APP) in intracellular vesicles, which plays a key role in age-related cognitive impairment. Most approaches to correct this altered processing aim to limit enzymatic activities that lead to toxic products, such as protein cleavage by β-secretase and the resulting amyloid β production. A viable alternative is to direct APP to cellular compartments where non-amyloidogenic mechanisms are favored. To this end, we exploited the molecular properties of the herpes simplex virus 1 (HSV-1) transport protein US9 to guide APP interaction with preferred endogenous targets. Specifically, we generated a US9 chimeric construct that facilitates APP processing through the non-amyloidogenic pathway and tested it in primary cortical neurons. In addition to reducing amyloid β production, our approach controls other APP-dependent biochemical steps that lead to neuronal deficits, including phosphorylation of APP and tau proteins. Notably, it also promotes the release of neuroprotective soluble αAPP. In contrast to other neuroprotective strategies, these US9-driven effects rely on the activity of endogenous neuronal proteins, which lends itself well to the study of fundamental mechanisms of APP processing/trafficking. Overall, this work introduces a new method to limit APP misprocessing and its cellular consequences without directly targeting secretase activity, offering a novel tool to reduce cognitive decline in pathologies such as Alzheimer’s disease and HIV-associated neurocognitive disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12035-022-03153-2

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 57

  1. Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185. https://doi.org/10.1126/science.1566067 · DOI · Paper page
  2. Hategan A, Bianchet MA, Steiner J et al (2017) HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity. Nat Struct Mol Biol 24:379–386. https://doi.org/10.1038/nsmb.3379 · DOI
  3. Stern AL, Ghura S, Gannon PJ et al (2018) BACE1 mediates HIV-associated and excitotoxic neuronal damage through an APP-dependent mechanism. J Neurosci 38:4288–4300. https://doi.org/10.1523/JNEUROSCI.1280-17.2018 · DOI
  4. Sinha S, Anderson JP, Barbour R et al (1999) Purification and cloning of amyloid precursor protein b-secretase from human brain. Nature 402:4. https://doi.org/10.1038/990114 · DOI · Paper page
  5. Vassar R, Bennett BD, Babu-Khan S et al (1999) β-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735–741. https://doi.org/10.1126/science.286.5440.735 · DOI · Paper page
  6. Yan R, Bienkowski MJ, Shuck ME et al (1999) Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity. Nature 402:533–537. https://doi.org/10.1038/990107 · DOI · Paper page
  7. Kimberly WT, LaVoie MJ, Ostaszewski BL et al (2003) γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2. PNAS 100:6382–6387. https://doi.org/10.1073/pnas.1037392100 · DOI · Paper page
  8. Takasugi N, Tomita T, Hayashi I et al (2003) The role of presenilin cofactors in the γ-secretase complex. Nature 422:438–441. https://doi.org/10.1038/nature01506 · DOI · Paper page
  9. Sisodia SS (1992) Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci USA 89:6075–6079 · DOI · Paper page
  10. Meziane H, Dodart J-C, Mathis C et al (1998) Memory-enhancing effects of secreted forms of the -amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci 95:12683–12688. https://doi.org/10.1073/pnas.95.21.12683 · DOI · Paper page
  11. Roch JM, Masliah E, Roch-Levecq AC et al (1994) Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. PNAS 91:7450–7454. https://doi.org/10.1073/pnas.91.16.7450 · DOI · Paper page
  12. Ohsawa I, Takamura C, Morimoto T et al (1999) Amino-terminal region of secreted form of amyloid precursor protein stimulates proliferation of neural stem cells. Eur J Neurosci 11:1907–1913. https://doi.org/10.1046/j.1460-9568.1999.00601.x · DOI
  13. Hayashi Y, Kashiwagi K, Ohta J et al (1994) Alzheimer amyloid protein precursor enhances proliferation of neural stem cells from fetal rat brain. Biochem Biophys Res Commun 205:936–943. https://doi.org/10.1006/bbrc.1994.2755 · DOI
  14. Giliberto L, Zhou D, Weldon R et al (2008) Evidence that the amyloid beta precursor protein-intracellular domain lowers the stress threshold of neurons and has a “regulated” transcriptional role. Mol Neurodegener 3:12. https://doi.org/10.1186/1750-1326-3-12 · DOI
  15. Hooper NM (2005) Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc Trans 33:335–338. https://doi.org/10.1042/BST0330335 · DOI
  16. Koo EH, Squazzo SL (1994) Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269:17386–17389. https://doi.org/10.1016/S0021-9258(17)32449-3 · DOI · Paper page
  17. Tan JZA, Gleeson PA (2019) The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer’s disease. Biochim Biophys Acta Biomembr 1861:697–712. https://doi.org/10.1016/j.bbamem.2018.11.013 · DOI · Paper page
  18. Tamayev R, Zhou D, D’Adamio L (2009) The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains. Mol Neurodegener 4:28. https://doi.org/10.1186/1750-1326-4-28 · DOI · Paper page
  19. Borg JP, Ooi J, Levy E, Margolis B (1996) The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 16:6229–6241. https://doi.org/10.1128/MCB.16.11.6229 · DOI · Paper page
  20. Pietrzik CU, Yoon I-S, Jaeger S et al (2004) FE65 Constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci 24:4259–4265. https://doi.org/10.1523/JNEUROSCI.5451-03.2004 · DOI · Paper page
  21. Roncarati R, Šestan N, Scheinfeld MH et al (2002) The γ-secretase-generated intracellular domain of β-amyloid precursor protein binds numb and inhibits notch signaling. Proc Natl Acad Sci USA 99:7102–7107. https://doi.org/10.1073/pnas.102192599 · DOI · Paper page
  22. Scheinfeld MH, Matsuda S, D’Adamio L (2003) JNK-interacting protein-1 promotes transcription of Aβ protein precursor but not Aβ precursor-like proteins, mechanistically different than Fe65. Proc Natl Acad Sci USA 100:1729–1734. https://doi.org/10.1073/pnas.0437908100 · DOI · Paper page
  23. McLoughlin DM, Miller CCJ (2008) The FE65 proteins and Alzheimer’s disease. J Neurosci Res 86:744–754. https://doi.org/10.1002/jnr.21532 · DOI
  24. Telese F, Bruni P, Donizetti A et al (2005) Transcription regulation by the adaptor protein Fe65 and the nucleosome assembly factor SET. EMBO Rep 6:77–82. https://doi.org/10.1038/sj.embor.7400309 · DOI
  25. Matrone C, Iannuzzi F, Annunziato L (2019) The Y682ENPTY687 motif of APP: progress and insights toward a targeted therapy for Alzheimer’s disease patients. Ageing Res Rev 52:120–128. https://doi.org/10.1016/j.arr.2019.04.003 · DOI
  26. Guénette S, Strecker P, Kins S (2017) APP protein family signaling at the synapse: insights from intracellular APP-binding proteins. Front Mol Neurosci 10. https://doi.org/10.3389/fnmol.2017.00087 · DOI
  27. Sullivan SE, Dillon GM, Sullivan JM, Ho A (2014) Mint proteins are required for synaptic activity-dependent amyloid precursor protein (APP) trafficking and amyloid β generation. J Biol Chem 289:15374–15383. https://doi.org/10.1074/jbc.M113.541003 · DOI · Paper page
  28. Suzuki T, Nakaya T (2008) Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions. J Biol Chem 283:29633–29637. https://doi.org/10.1074/jbc.R800003200 · DOI
  29. Saito Y, Sano Y, Vassar R et al (2008) X11 proteins regulate the translocation of amyloid β-protein precursor (APP) into detergent-resistant membrane and suppress the amyloidogenic cleavage of APP by β-site-cleaving enzyme in brain. J Biol Chem 283:35763–35771. https://doi.org/10.1074/jbc.M801353200 · DOI · Paper page
  30. Brandimarti R, Hill GS, Geiger JD, Meucci O (2017) The lipid raft-dwelling protein US9 can be manipulated to target APP compartmentalization, APP processing, and neurodegenerative disease pathogenesis. Sci Rep 7:15103. https://doi.org/10.1038/s41598-017-15128-8 · DOI
  31. Brideau AD, Banfield BW, Enquist LW (1998) The Us9 gene product of pseudorabies virus, an alphaherpesvirus, is a phosphorylated, tail-anchored type II membrane protein. J Virol 72:4560–4570 · DOI
  32. Brideau AD, Eldridge MG, Enquist LW (2000) Directional transneuronal infection by pseudorabies virus is dependent on an acidic internalization motif in the Us9 cytoplasmic tail. J Virol 74:4549–4561 · DOI
  33. LaVail JH, Tauscher AN, Sucher A et al (2007) Viral regulation of the long distance axonal transport of herpes simplex virus nucleocapsid. Neuroscience 146:974–985. https://doi.org/10.1016/j.neuroscience.2007.02.010 · DOI
  34. Wisner TW, Sugimoto K, Howard PW et al (2011) Anterograde transport of herpes simplex virus capsids in neurons by both separate and married mechanisms. J Virol 85:5919–5928. https://doi.org/10.1128/JVI.00116-11 · DOI
  35. Pedrazzi M, Nash B, Meucci O, Brandimarti R (2014) Molecular features contributing to virus-independent intracellular localization and dynamic behavior of the herpesvirus transport protein US9. PLoS ONE 9:e104634. https://doi.org/10.1371/journal.pone.0104634 · DOI
  36. Sengupta R, Burbassi S, Shimizu S et al (2009) Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons. J Neurosci 29:2534–2544. https://doi.org/10.1523/JNEUROSCI.5865-08.2009 · DOI
  37. Nash B, Tarn K, Irollo E et al (2019) Morphine-induced modulation of endolysosomal iron mediates upregulation of ferritin heavy chain in cortical neurons. eNeuro 6. https://doi.org/10.1523/ENEURO.0237-19.2019 · DOI
  38. Festa LK, Irollo E, Platt BJ et al (2020) CXCL12-induced rescue of cortical dendritic spines and cognitive flexibility. eLife 9:e49717. https://doi.org/10.7554/eLife.49717 · DOI
  39. Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. https://doi.org/10.1038/nmeth.2019 · DOI · Paper page
  40. Liu C, Xu P, Lamouille S et al (2009) TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. Mol Cell 35:26–36. https://doi.org/10.1016/j.molcel.2009.06.018 · DOI · Paper page
  41. Mullan M, Crawford F, Axelman K et al (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N–terminus of β–amyloid. Nat Genet 1:345–347. https://doi.org/10.1038/ng0892-345 · DOI · Paper page
  42. Brideau AD, del Rio T, Wolffe EJ, Enquist LW (1999) Intracellular trafficking and localization of the pseudorabies virus Us9 type II envelope protein to host and viral membranes. J Virol 73:4372–4384 · DOI
  43. Miller CCJ, McLoughlin DM, Lau K-F et al (2006) The X11 proteins, abeta production and Alzheimer’s disease. Trends Neurosci 29:280–285. https://doi.org/10.1016/j.tins.2006.03.001 · DOI · Paper page
  44. Margolis B, Borg J-P, Straight S, Meyer D (1999) The function of PTB domain proteins. Kidney Int 56:1230–1237. https://doi.org/10.1046/j.1523-1755.1999.00700.x · DOI · Paper page
  45. Seegar TCM, Killingsworth LB, Saha N et al (2017) Structural basis for regulated proteolysis by the α-secretase ADAM10. Cell 171:1638-1648.e7. https://doi.org/10.1016/j.cell.2017.11.014 · DOI · Paper page
  46. Koo EH, Squazzo SL, Selkoe DJ, Koo CH (1996) Trafficking of cell-surface amyloid beta-protein precursor. I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody. J Cell Sci 109(Pt 5):991–998 · DOI · Paper page
  47. Ulery PG, Beers J, Mikhailenko I et al (2000) Modulation of β-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP): evidence that lrp contributes to the pathogenesis of Alzheimer’s disease *. J Biol Chem 275:7410–7415. https://doi.org/10.1074/jbc.275.10.7410 · DOI · Paper page
  48. Lee M-S, Kao S-C, Lemere CA et al (2003) APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 163:83–95. https://doi.org/10.1083/jcb.200301115 · DOI · Paper page
  49. Zhang T, Chen D, Lee TH (2020) Phosphorylation signaling in APP processing in Alzheimer’s disease. Int J Mol Sci 21:209. https://doi.org/10.3390/ijms21010209 · DOI
  50. Lombino F, Biundo F, Tamayev R et al (2013) An intracellular threonine of amyloid-β precursor protein mediates synaptic plasticity deficits and memory loss. PLoS ONE 8:e57120. https://doi.org/10.1371/journal.pone.0057120 · DOI · Paper page
  51. Foidl BM, Humpel C (2018) Differential hyperphosphorylation of tau-S199, -T231 and -S396 in organotypic brain slices of Alzheimer mice. A model to study early tau hyperphosphorylation using okadaic acid. Front Aging Neurosci 10:113. https://doi.org/10.3389/fnagi.2018.00113 · DOI
  52. Luna-Viramontes NI, Campa-Córdoba BB, Ontiveros-Torres MÁ et al (2020) PHF-core tau as the potential initiating event for tau pathology in Alzheimer’s disease. Front Cell Neurosci 14:247. https://doi.org/10.3389/fncel.2020.00247 · DOI
  53. Zheng H, Koo EH (2011) Biology and pathophysiology of the amyloid precursor protein. Mol Neurodegener 6:27. https://doi.org/10.1186/1750-1326-6-27 · DOI · Paper page
  54. Tapia-Rojas C, Cabezas-Opazo F, Deaton CA et al (2018) It’s all about tau. Prog Neurobiol. https://doi.org/10.1016/j.pneurobio.2018.12.005 · DOI · Paper page
  55. Deng J, Habib A, Obregon DF et al (2015) Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway. J Neurochem 135:630–637. https://doi.org/10.1111/jnc.13351 · DOI
  56. Bell KFS, Zheng L, Fahrenholz F, Cuello AC (2008) ADAM-10 over-expression increases cortical synaptogenesis. Neurobiol Aging 29:554–565. https://doi.org/10.1016/j.neurobiolaging.2006.11.004 · DOI
  57. Richter MC, Ludewig S, Winschel A et al (2018) Distinct in vivo roles of secreted APP ectodomain variants APPsα and APPsβ in regulation of spine density, synaptic plasticity, and cognition. EMBO J 37:e98335. https://doi.org/10.15252/embj.201798335 · DOI

Metadata

Authors
Brandimarti, R., Irollo, E., & Meucci, O.
Venue
Molecular Neurobiology
Published
2022-12-28
Volume
60
Issue
4
Pages
1811-1825
ISSN
  • 0893-7648
  • 1559-1182
Cited by
3
References
19
Language
en
Licence
Funders
  • Center for Scientific Review (DA032444, DA040519, DA015014)
  • Ministero dell’Istruzione, dell’Università e della Ricerca (RFO2017)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities. https://app.cochat.ai/papers/10.1007/s12035-022-03153-2
The paper
Brandimarti, R., Irollo, E., & Meucci, O. (2023). The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities. Molecular Neurobiology. https://doi.org/10.1007/s12035-022-03153-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.